Patent · US Active

Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders

US9850532B2 · kind B2 · utility

0Cited by

12References

4Claims

0Family size

Assignee

EPIGENOMICS AG · DE

Inventors

Andrew Z. Sledziewski · Shoreline, US
Catherine E. Lofton-Day · Brier, US
Reimo Tetzner · Berlin, DE
Juergen Distler · Berlin, DE
Fabian Model · Berlin, DE
Shannon Payne · Seattle, US

Key dates

Filing date	Aug 17, 2016
Grant date	Dec 26, 2017
Priority date	—
Expiry date	Aug 17, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides methods, nucleic acids and kits for detecting prostate cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.